Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 10 | 2022 | 111 | 3.560 |
Why?
|
| Models, Biological | 16 | 2022 | 1127 | 3.070 |
Why?
|
| Models, Theoretical | 7 | 2022 | 244 | 2.500 |
Why?
|
| Bioreactors | 8 | 2019 | 30 | 2.320 |
Why?
|
| Oxygen | 7 | 2022 | 237 | 1.810 |
Why?
|
| Nerve Regeneration | 5 | 2022 | 30 | 1.670 |
Why?
|
| Models, Cardiovascular | 4 | 2020 | 67 | 1.530 |
Why?
|
| Microcirculation | 3 | 2020 | 40 | 1.530 |
Why?
|
| Cell Culture Techniques | 6 | 2021 | 177 | 1.520 |
Why?
|
| Peripheral Nerve Injuries | 2 | 2021 | 6 | 1.100 |
Why?
|
| Tissue Culture Techniques | 2 | 2021 | 26 | 1.050 |
Why?
|
| Microvessels | 3 | 2020 | 17 | 0.960 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.960 |
Why?
|
| Ventilators, Mechanical | 2 | 2021 | 21 | 0.920 |
Why?
|
| Biological Transport | 3 | 2021 | 278 | 0.870 |
Why?
|
| Shock | 1 | 2020 | 22 | 0.870 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 170 | 0.850 |
Why?
|
| Shock, Septic | 1 | 2020 | 62 | 0.820 |
Why?
|
| Retinal Degeneration | 1 | 2020 | 26 | 0.810 |
Why?
|
| Drug Therapy | 1 | 2020 | 54 | 0.800 |
Why?
|
| Stress, Mechanical | 5 | 2019 | 122 | 0.790 |
Why?
|
| Global Health | 1 | 2021 | 135 | 0.790 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 105 | 0.780 |
Why?
|
| Rheology | 3 | 2019 | 54 | 0.720 |
Why?
|
| Pandemics | 2 | 2021 | 343 | 0.700 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 305 | 0.660 |
Why?
|
| Shear Strength | 3 | 2019 | 21 | 0.660 |
Why?
|
| Tissue Scaffolds | 5 | 2022 | 67 | 0.650 |
Why?
|
| Peripheral Nerves | 3 | 2022 | 20 | 0.650 |
Why?
|
| Actins | 1 | 2018 | 245 | 0.630 |
Why?
|
| Vascular Neoplasms | 2 | 2020 | 12 | 0.610 |
Why?
|
| Neoplasms | 4 | 2019 | 986 | 0.610 |
Why?
|
| Rats | 8 | 2021 | 1819 | 0.610 |
Why?
|
| Cell Lineage | 2 | 2014 | 240 | 0.590 |
Why?
|
| Hydrogels | 3 | 2021 | 80 | 0.580 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 540 | 0.570 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 41 | 0.550 |
Why?
|
| Cells | 1 | 2014 | 29 | 0.550 |
Why?
|
| Computer Simulation | 4 | 2020 | 410 | 0.530 |
Why?
|
| Algorithms | 2 | 2020 | 879 | 0.530 |
Why?
|
| Humans | 32 | 2022 | 48168 | 0.530 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2021 | 19 | 0.490 |
Why?
|
| Animals | 18 | 2021 | 18017 | 0.440 |
Why?
|
| Brain | 1 | 2018 | 1154 | 0.410 |
Why?
|
| Cell Proliferation | 5 | 2017 | 890 | 0.370 |
Why?
|
| Collagen | 3 | 2019 | 122 | 0.370 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 88 | 0.370 |
Why?
|
| Blastocyst | 1 | 2009 | 67 | 0.360 |
Why?
|
| Morphogenesis | 1 | 2009 | 113 | 0.360 |
Why?
|
| Mathematical Concepts | 3 | 2020 | 4 | 0.360 |
Why?
|
| Hemodynamics | 2 | 2020 | 179 | 0.350 |
Why?
|
| Hydrodynamics | 3 | 2018 | 24 | 0.330 |
Why?
|
| Endocytosis | 2 | 2021 | 151 | 0.330 |
Why?
|
| Eyelids | 2 | 2017 | 7 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 221 | 0.300 |
Why?
|
| Biocompatible Materials | 3 | 2021 | 121 | 0.300 |
Why?
|
| Cell Survival | 2 | 2020 | 539 | 0.290 |
Why?
|
| Oxygen Consumption | 3 | 2019 | 186 | 0.280 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 199 | 0.270 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 56 | 0.270 |
Why?
|
| Regional Blood Flow | 3 | 2020 | 91 | 0.270 |
Why?
|
| Cumulus Cells | 1 | 2021 | 4 | 0.230 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 1257 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2022 | 535 | 0.220 |
Why?
|
| Manufacturing Industry | 1 | 2021 | 4 | 0.220 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 41 | 0.220 |
Why?
|
| Diffusion | 3 | 2021 | 76 | 0.220 |
Why?
|
| Policy | 1 | 2021 | 19 | 0.220 |
Why?
|
| Materials Testing | 3 | 2019 | 75 | 0.220 |
Why?
|
| Models, Neurological | 1 | 2021 | 72 | 0.220 |
Why?
|
| International Cooperation | 1 | 2021 | 83 | 0.210 |
Why?
|
| Heart | 2 | 2014 | 212 | 0.210 |
Why?
|
| Polymers | 2 | 2013 | 263 | 0.210 |
Why?
|
| Mesentery | 1 | 2020 | 14 | 0.210 |
Why?
|
| Splanchnic Circulation | 1 | 2020 | 14 | 0.210 |
Why?
|
| Noninvasive Ventilation | 1 | 2021 | 65 | 0.200 |
Why?
|
| Blood Pressure | 2 | 2020 | 474 | 0.200 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 128 | 0.200 |
Why?
|
| Blepharoptosis | 2 | 2017 | 4 | 0.200 |
Why?
|
| Extracellular Fluid | 1 | 2019 | 7 | 0.200 |
Why?
|
| Xenobiotics | 1 | 2019 | 12 | 0.200 |
Why?
|
| Drug Carriers | 1 | 2021 | 152 | 0.190 |
Why?
|
| Equipment Design | 3 | 2020 | 273 | 0.190 |
Why?
|
| Coculture Techniques | 1 | 2018 | 87 | 0.190 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 216 | 0.180 |
Why?
|
| Numerical Analysis, Computer-Assisted | 2 | 2015 | 6 | 0.180 |
Why?
|
| Mice | 4 | 2019 | 9156 | 0.180 |
Why?
|
| Pericytes | 1 | 2018 | 14 | 0.180 |
Why?
|
| Optogenetics | 1 | 2018 | 19 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 116 | 0.180 |
Why?
|
| Kinetics | 3 | 2021 | 726 | 0.170 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 103 | 0.170 |
Why?
|
| Blinking | 2 | 2017 | 3 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 164 | 0.170 |
Why?
|
| Computational Biology | 1 | 2019 | 286 | 0.170 |
Why?
|
| Nanoparticles | 2 | 2021 | 425 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 177 | 0.170 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 61 | 0.170 |
Why?
|
| Coronary Circulation | 2 | 2014 | 43 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 30 | 0.160 |
Why?
|
| Suture Techniques | 1 | 2017 | 71 | 0.160 |
Why?
|
| Cattle | 1 | 2017 | 300 | 0.160 |
Why?
|
| Coronary Vessels | 2 | 2014 | 117 | 0.150 |
Why?
|
| Chemotaxis | 1 | 2014 | 43 | 0.140 |
Why?
|
| Liver | 1 | 2019 | 715 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 10 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 68 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1138 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 155 | 0.130 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2013 | 7 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 17 | 0.130 |
Why?
|
| Sutures | 1 | 2013 | 36 | 0.130 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 37 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 104 | 0.130 |
Why?
|
| Cell Death | 1 | 2014 | 242 | 0.130 |
Why?
|
| Capillaries | 2 | 2010 | 30 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 63 | 0.120 |
Why?
|
| Video Recording | 1 | 2013 | 98 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2014 | 333 | 0.120 |
Why?
|
| Glucuronic Acid | 1 | 2011 | 17 | 0.120 |
Why?
|
| Hexuronic Acids | 1 | 2011 | 21 | 0.120 |
Why?
|
| Child | 1 | 2020 | 3604 | 0.120 |
Why?
|
| Cell Line | 1 | 2017 | 1977 | 0.120 |
Why?
|
| Alginates | 1 | 2011 | 34 | 0.110 |
Why?
|
| Lactic Acid | 1 | 2011 | 60 | 0.110 |
Why?
|
| Porosity | 3 | 2019 | 30 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2081 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1247 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2008 | 15 | 0.090 |
Why?
|
| Glucose | 1 | 2011 | 385 | 0.090 |
Why?
|
| Tensile Strength | 2 | 2019 | 35 | 0.080 |
Why?
|
| Elastic Modulus | 2 | 2019 | 36 | 0.080 |
Why?
|
| Biomarkers | 1 | 2009 | 952 | 0.070 |
Why?
|
| Myocardium | 2 | 2014 | 195 | 0.050 |
Why?
|
| Biomechanical Phenomena | 2 | 2013 | 220 | 0.050 |
Why?
|
| Neurites | 1 | 2019 | 23 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 157 | 0.050 |
Why?
|
| Tendons | 1 | 2019 | 13 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2021 | 400 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2019 | 98 | 0.050 |
Why?
|
| Diphosphates | 1 | 2018 | 9 | 0.050 |
Why?
|
| Transplants | 1 | 2018 | 7 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2018 | 24 | 0.050 |
Why?
|
| Nerve Transfer | 1 | 2018 | 4 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 20 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2018 | 18 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2019 | 48 | 0.050 |
Why?
|
| Betacoronavirus | 1 | 2020 | 142 | 0.050 |
Why?
|
| Gadolinium | 1 | 2018 | 55 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2018 | 169 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2018 | 55 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 224 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 230 | 0.040 |
Why?
|
| Stilbenes | 1 | 2018 | 46 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 220 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2018 | 73 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2019 | 165 | 0.040 |
Why?
|
| Glioma | 1 | 2018 | 94 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 13107 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2018 | 146 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 13431 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 510 | 0.040 |
Why?
|
| Forehead | 1 | 2017 | 18 | 0.040 |
Why?
|
| Female | 4 | 2021 | 26086 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 176 | 0.040 |
Why?
|
| Contrast Media | 1 | 2018 | 288 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 20 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 194 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 2014 | 22 | 0.040 |
Why?
|
| Aged | 2 | 2021 | 10785 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 55 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 59 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 143 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 34 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2014 | 20 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 48 | 0.030 |
Why?
|
| Quinolines | 1 | 2014 | 36 | 0.030 |
Why?
|
| Hardness | 1 | 2013 | 7 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 65 | 0.030 |
Why?
|
| Neurons | 1 | 2019 | 769 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2013 | 19 | 0.030 |
Why?
|
| Oculomotor Muscles | 1 | 2013 | 12 | 0.030 |
Why?
|
| Rhodamines | 1 | 2013 | 19 | 0.030 |
Why?
|
| Muscles | 1 | 2014 | 161 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 72 | 0.030 |
Why?
|
| Clathrin | 1 | 2013 | 25 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 65 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2013 | 25 | 0.030 |
Why?
|
| Male | 3 | 2021 | 23047 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2013 | 27 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 235 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 82 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2014 | 2749 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 137 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2014 | 178 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 3563 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 2927 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1809 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2013 | 713 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 269 | 0.030 |
Why?
|
| Physics | 1 | 2009 | 11 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2009 | 25 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 6 | 0.020 |
Why?
|
| Biology | 1 | 2009 | 19 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2008 | 26 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3187 | 0.020 |
Why?
|